Correlation Between Crinetics Pharmaceuticals and 2Seventy Bio
Can any of the company-specific risk be diversified away by investing in both Crinetics Pharmaceuticals and 2Seventy Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crinetics Pharmaceuticals and 2Seventy Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crinetics Pharmaceuticals and 2Seventy Bio, you can compare the effects of market volatilities on Crinetics Pharmaceuticals and 2Seventy Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crinetics Pharmaceuticals with a short position of 2Seventy Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crinetics Pharmaceuticals and 2Seventy Bio.
Diversification Opportunities for Crinetics Pharmaceuticals and 2Seventy Bio
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Crinetics and 2Seventy is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Crinetics Pharmaceuticals and 2Seventy Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 2Seventy Bio and Crinetics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crinetics Pharmaceuticals are associated (or correlated) with 2Seventy Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 2Seventy Bio has no effect on the direction of Crinetics Pharmaceuticals i.e., Crinetics Pharmaceuticals and 2Seventy Bio go up and down completely randomly.
Pair Corralation between Crinetics Pharmaceuticals and 2Seventy Bio
Given the investment horizon of 90 days Crinetics Pharmaceuticals is expected to generate 0.44 times more return on investment than 2Seventy Bio. However, Crinetics Pharmaceuticals is 2.28 times less risky than 2Seventy Bio. It trades about 0.0 of its potential returns per unit of risk. 2Seventy Bio is currently generating about -0.22 per unit of risk. If you would invest 5,715 in Crinetics Pharmaceuticals on August 28, 2024 and sell it today you would lose (38.00) from holding Crinetics Pharmaceuticals or give up 0.66% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Crinetics Pharmaceuticals vs. 2Seventy Bio
Performance |
Timeline |
Crinetics Pharmaceuticals |
2Seventy Bio |
Crinetics Pharmaceuticals and 2Seventy Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Crinetics Pharmaceuticals and 2Seventy Bio
The main advantage of trading using opposite Crinetics Pharmaceuticals and 2Seventy Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crinetics Pharmaceuticals position performs unexpectedly, 2Seventy Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 2Seventy Bio will offset losses from the drop in 2Seventy Bio's long position.Crinetics Pharmaceuticals vs. Eliem Therapeutics | Crinetics Pharmaceuticals vs. Scpharmaceuticals | Crinetics Pharmaceuticals vs. Milestone Pharmaceuticals | Crinetics Pharmaceuticals vs. Seres Therapeutics |
2Seventy Bio vs. Puma Biotechnology | 2Seventy Bio vs. Iovance Biotherapeutics | 2Seventy Bio vs. Sarepta Therapeutics | 2Seventy Bio vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |